AI-Powered smartwatch could forecast Parkinson's worsening

NCT ID NCT07189468

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will test whether artificial intelligence (AI) can predict how Parkinson's disease will progress and how patients will respond to medication. One hundred people with Parkinson's will wear a smartwatch and use a mobile app for one year. The AI models will analyze data from the watch, along with clinical and genetic information, to see if they can forecast motor decline and side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps doctors personalize Parkinson's treatment and predict how the disease will progress.
What could go wrong: This is an early study with only 100 people. The AI models may not work as well in real-world settings or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (DISORDER)

Contacts and locations

Locations

Hospital Ruber Internacional

Madrid, Spain
Queen Mary University of London

London, United Kingdom
Technische Universität Dresden

Dresden, Germany
University Hospital of Toulouse

Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.